-
Login
-
Digital Edition
-
Print Edition
- Most Commented
- Most Commented
- Most Emailed
- Most Emailed
- Popular
- Popular
« News Home
Study buoys Hubbard biotech company
Tweetstaff report
HUBBARD — NanoLogix, a local biotechnology company, said an independent study shows that its testing methods for anthrax and bubonic plague are faster than conventional methods.
The research by Battelle Memorial Institute in Columbus was published in the current online issue of Letters in Applied Microbiology.
The authors found that NanoLogix technology displayed colonies of anthrax in six hours, compared with 24 hours with the fastest traditional methods.
The study also found that the NanoLogix technology allowed viewing of cultures of bubonic plague twice as fast as traditional petri-dish methods.
Bret Barnhizer, NanoLogix chief executive, said Monday he was elated by the results of the study and is looking forward to broader public awareness of the company’s technology.
The company has two testing methods that it says can be used on a wide variety of threats, including meningitis and salmonella.
NanoLogix has an office at 843 N. Main St. and has plans to bring production of test kits there. Now, limited production is being handled in Cincinnati, where research is conducted.
The company’s stock traded at 9 cents Monday, up 1 cent.
Comments
This must be the major positive announcement that three weeks ago Barnizer said he exepected to make in 2 to 3 weeks. It is pretty big. If he can just line up the 500K needed to begin large scale production . . . A report on Yahoo mb is that the clean room build out has commenced, Anyone have any info on that? People need work and here is worthwhile means of putting them to work while advancing medicine and national security for pennies. Government heads should roll it it doesn't come up with the pennies needed by Barnhizer.